Mastura Monif

Projects

Projects per year 2018 2020 2021 2022 2023 2024 2030

• 10 Active
• 14 Finished

Projects per year

Search results

• Active

  The ACRF Centre for Dynamic Immuno-Oncology (CDIO)

  Shackleton, M. (Primary Chief Investigator (PCI)), Cherk, M. (Chief Investigator (CI)), Naranbhai, V. (Chief Investigator (CI)), McLean, C. (Chief Investigator (CI)), Monif, M. (Chief Investigator (CI)), Si Lun Tam, C. (Chief Investigator (CI)), Kalff, A. (Chief Investigator (CI)), Fleming, S. (Chief Investigator (CI)), Mar, V. (Chief Investigator (CI)), Ge, Z. (Chief Investigator (CI)) & Cheung, J. (Project Manager)

  7/04/25 → 7/01/30

  Project: Research

• Electroencephalogram (EEG) in autoimmune encephalitis diagnosis and prognosis.

  Tan, T. (Primary Chief Investigator (PCI)), Monif, M. (Associate Investigator (AI)), Wesselingh, R. (Associate Investigator (AI)), Seery, N. (Associate Investigator (AI)), Kwan, P. (Chief Investigator (CI)) & O'Brien, T. (Chief Investigator (CI))

  1/01/25 → 1/01/26

  Project: Research

• An open-label, multi-center, phase I/II study to assess safety, disease progression, and cellular kinetics following YTB323 administration in participants with non-active Progressive Multiple Sclerosis (PMS)

  Monif, M. (Primary Chief Investigator (PCI))

  18/11/24 → 2/05/28

  Project: Research

• An open-label, multi-center, phase 1/2 study to assess safety, efficacy, and cellular kinetics of YTB323 in participants with Relapsing Multiple Sclerosis with breakthrough disease activity during previous treatment with a highly efficacious therapy

  Monif, M. (Primary Chief Investigator (PCI))

  1/10/24 → 30/09/26

  Project: Research

• CureMOG: A randomised double-blind placebo-controlled multicentre phase III clinical trial for the treatment of MOGAD

  Ramanathan, S. (Primary Chief Investigator (PCI)), Butzkueven, H. (Chief Investigator (CI)), Brown, D. A. (Chief Investigator (CI)), Van Der Walt, A. (Chief Investigator (CI)), Kalincik, T. (Chief Investigator (CI)), Miteff, C. (Associate Investigator (AI)), Fraser, C. (Associate Investigator (AI)), Klistorner, A. (Associate Investigator (AI)), Hardy, T. A. (Associate Investigator (AI)), Barnett, M. H. (Chief Investigator (CI)), Broadley, S. (Chief Investigator (CI)), Spelman, T. D. (Chief Investigator (CI)), Lindley, R. I. (Chief Investigator (CI)), Brilot-Turville, F. (Chief Investigator (CI)), Dale, R. C. (Chief Investigator (CI)), Slee, M. (Chief Investigator (CI)), Lewfelar, J. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Lechner-Scott, J. (Chief Investigator (CI)), Monif, M. (Associate Investigator (AI)) & George, S. (Associate Investigator (AI))

  1/06/24 → 31/05/29

  Project: Research

• Australian Autoimmune Encephalitis Consortium Study - improving diagnosis, outcomes, and quality of care for patients with this devastating neurological illness.

  Monif, M. (Primary Chief Investigator (PCI)), Wesselingh, R. (Chief Investigator (CI)), Butzkueven, H. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Malpas, C. (Chief Investigator (CI)), Haartsen, J. (Chief Investigator (CI)), Hardy, T. A. (Chief Investigator (CI)), Gillis, D. (Chief Investigator (CI)), Seneviratne, U. (Chief Investigator (CI)), Blum, S. (Chief Investigator (CI)), Nesbitt, C. S. (Chief Investigator (CI)), Heiss, L. (Chief Investigator (CI)), Macdonell, R. A. L. (Chief Investigator (CI)), Mykytowycz, M. (Chief Investigator (CI)), Sanfilippo, P. (Chief Investigator (CI)), D'Souza, W. J. (Associate Investigator (AI)), Kulkarni, J. (Associate Investigator (AI)), Buzzard, K. (Associate Investigator (AI)), O'Brien, T. (Associate Investigator (AI)), Broadley, S. (Associate Investigator (AI)), Taylor, B. V. (Associate Investigator (AI)), MacIntyre, J. (Associate Investigator (AI)), Barton, J. (Associate Investigator (AI)), Swayne, A. (Associate Investigator (AI)), Alpitsis, R. (Associate Investigator (AI)), Harding, I. (Associate Investigator (AI)), Butler, E. (Associate Investigator (AI)), Ramanathan, S. (Associate Investigator (AI)), Giles, A. (Associate Investigator (AI)) & Gadi, M. (Associate Investigator (AI))

  1/03/24 → 31/12/27

  Project: Research

• Fatigue In Relapsing Multiple Sclerosis Epstein Barr Virus (EBV) treatment trial (FIRMS-EBV)

  Hardy, T. A. (Primary Chief Investigator (PCI)), Giovannoni, G. (Chief Investigator (CI)), Kilpatrick, T. J. (Chief Investigator (CI)), Potter, A. (Chief Investigator (CI)), Gaudieri, S. (Chief Investigator (CI)), Monif, M. (Chief Investigator (CI)), Parratt, J. D. E. (Chief Investigator (CI)), Bruestle, A. (Chief Investigator (CI)), Barton, J. (Chief Investigator (CI)), Lloyd, A. R. (Chief Investigator (CI)), Phan, T. (Chief Investigator (CI)), Vucic, O. (Chief Investigator (CI)), Ponsonby, A. L. (Chief Investigator (CI)) & Butzkueven, H. (Chief Investigator (CI))

  1/07/23 → 30/06/28

  Project: Research

• Targeting sphingolipid metabolism to combat the development of chronic fatigue syndrome.

  Xiao, J. (Primary Chief Investigator (PCI)), Orian, J. M. (Chief Investigator (CI)) & Monif, M. (Chief Investigator (CI))

  1/04/23 → 1/04/26

  Project: Research

• A randomized, double-blind, placebo- controlled, multicenter, Phase 3, PIVOTAL study with an open-label Extension period to evaluate the efficacy and safety of rozanolixizumab in adult participants with Myelin oligodendrocyte glycoprotein (MOG) ANTIBODY-ASSOCIATED disease (MOG-AD).

  Monif, M. (Primary Chief Investigator (PCI))

  13/05/22 → 31/12/26

  Project: Research

• Glioblastoma - inhibition of P2X7R as a potential therapeutic target for treatment of this aggressive cancer.

  Monif, M. (Primary Chief Investigator (PCI)), Hunn, M. (Chief Investigator (CI)), Drummond, K. J. (Associate Investigator (AI)), McLean, C. (Associate Investigator (AI)), Jones, N. (Associate Investigator (AI)), Sanfilippo, P. (Associate Investigator (AI)) & O'Brien, T. (Associate Investigator (AI))

  1/01/22 → 31/12/25

  Project: Research